Colin Forde

Colin Forde
2011/12

Colin Forde, along with his fellow BioInnovate colleagues Wayne Allen and Liam Mullins uncovered an unmet, underserved clinical need to embolise patients reliably in one shot. Stemming from this, they successfully applied for Enterprise Ireland Commercialisation Funding to de risk the project for Series A investment. In 2014, after spinning out from National University of Ireland Galway to form Embo Medical, the team obtained a further €3 million in funding from Enterprise Ireland and AIB’s Seed Capital Fund. Subsequently in 2016, Embo Medical was acquired by CR Bard’s subsidiary Clearstream for almost €43.5 million. Following the acquisition completion, Colin is working on a number of new projects in the Medtech space.

Our Location

Situated on the prestigious campus of National University of Ireland Galway within the medieval city of Galway, European Capital of Culture in 2020, with equal easy access to the wilderness of Connemara in the west and the European mainland in the east, BioInnovate boasts a superb location.

Our affiliation with Stanford BioDesign has helped us to become one of the world’s leading innovation hubs with an immense debt of gratitude owed to Enterprise Ireland for both their financial and professional support in helping BioInnovate grow.

Contact Us Today
BioInnovate Ireland Block E
National University of Ireland Galway,
Ireland +353 (0)91 492 646